A Novel Technique for the Removal of Pterygiums

December 26, 2014 updated by: Dr. Kim Jebodhsingh, The University of The West Indies

The aim of this study is to introduce a new surgical technique for the removal of pterygiums that entails the use of bipolar electrocautery to secure the graft, rather than sutures.

With this, the objective is to evaluate the benefits of a new technique for pterygium surgery with respect to postoperative patient comfort, surgery time, cost and recurrence rate.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bridgetown, Barbados
        • Queen Elizabeth Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with one or more pterygiums over age 18

Exclusion Criteria:

  • Patients with glaucoma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Sutures
After pterygium removal the conjunctival graft to cover bare sclera will be secured with interrupted 8.0 polyglactin sutures.
  • Pterygium dissected off, corneal bed burred smooth and autograft harvested as per usual technique.
  • Conjunctiva undermined at the recipient site.
  • Graft is slid into place The graft is secured to host conjunctiva using 7 interrupted sutures
Other Names:
  • Polyglactin, Vicryl
EXPERIMENTAL: Cautery
After pterygium removal the conjunctival graft to cover bare sclera will be secured with bipolar electrocautery, power set at 25 until whitening of tissue observed.
  • Pterygium dissected off, corneal bed burred smooth and autograft harvested as per usual technique.
  • Conjunctiva undermined at the recipient site.
  • Relaxing incisions placed at the corners of the recipient site.
  • Graft is slid into place
  • Graft / host interface is gently dried with a Qtip
  • Bipolar cautery is applied after grasping the graft and host conjunctiva gently between cautery forceps.

    • Power setting: 25.
    • Duration of cautery: 4 -5 seconds; the tissue should whiten and contract as desiccation and coagulation take place. Some charring may occur.
  • Counter traction is applied to the conjunctiva as the cautery forceps are gently teased off
  • Cautery is applied at the 4 apices of the graft then in between these points.
Other Names:
  • Mentor O&O Wetfield Coagulator

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Discomfort
Time Frame: Day 1

Grading of patients' symptoms (pain, foreign body sensation, irritation, and epiphora) will be done using a 5-point scale. The scale ranges from 0 to 4:

0 = no symptom at all;

  1. = presence of the symptom but easily tolerated;
  2. = presence of the symptom causing some discomfort;
  3. = presence of the symptom causing discomfort that interferes with usual activity or sleep;
  4. = presence of the symptom that completely interferes with usual activity or sleep.
Day 1
Patient Discomfort
Time Frame: Week 1

Grading of patients' symptoms (pain, foreign body sensation, irritation, and epiphora) will be done using a 5-point scale. The scale ranges from 0 to 4:

0 = no symptom at all;

  1. = presence of the symptom but easily tolerated;
  2. = presence of the symptom causing some discomfort;
  3. = presence of the symptom causing discomfort that interferes with usual activity or sleep;
  4. = presence of the symptom that completely interferes with usual activity or sleep.
Week 1
Patient Discomfort
Time Frame: Week 2

Grading of patients' symptoms (pain, foreign body sensation, irritation, and epiphora) will be done using a 5-point scale. The scale ranges from 0 to 4:

0 = no symptom at all;

  1. = presence of the symptom but easily tolerated;
  2. = presence of the symptom causing some discomfort;
  3. = presence of the symptom causing discomfort that interferes with usual activity or sleep;
  4. = presence of the symptom that completely interferes with usual activity or sleep.
Week 2
Patient Discomfort
Time Frame: Week 3

Grading of patients' symptoms (pain, foreign body sensation, irritation, and epiphora) will be done using a 5-point scale. The scale ranges from 0 to 4:

0 = no symptom at all;

  1. = presence of the symptom but easily tolerated;
  2. = presence of the symptom causing some discomfort;
  3. = presence of the symptom causing discomfort that interferes with usual activity or sleep;
  4. = presence of the symptom that completely interferes with usual activity or sleep.
Week 3
Patient Discomfort
Time Frame: Week 7

Grading of patients' symptoms (pain, foreign body sensation, irritation, and epiphora) will be done using a 5-point scale. The scale ranges from 0 to 4:

0 = no symptom at all;

  1. = presence of the symptom but easily tolerated;
  2. = presence of the symptom causing some discomfort;
  3. = presence of the symptom causing discomfort that interferes with usual activity or sleep;
  4. = presence of the symptom that completely interferes with usual activity or sleep.
Week 7
Patient Discomfort
Time Frame: 3 months

Grading of patients' symptoms (pain, foreign body sensation, irritation, and epiphora) will be done using a 5-point scale. The scale ranges from 0 to 4:

0 = no symptom at all;

  1. = presence of the symptom but easily tolerated;
  2. = presence of the symptom causing some discomfort;
  3. = presence of the symptom causing discomfort that interferes with usual activity or sleep;
  4. = presence of the symptom that completely interferes with usual activity or sleep.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operating time
Time Frame: day 1
Analysis. start time of operation, start time of conjunctival graft attachment and end time of operation will be recorded.
day 1

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operating Cost
Time Frame: day 1
Cost Benefit Analysis. Total cost of pterygium surgery using sutures for graft attachment versus cost using cautery for graft attachment will be calculated and compared.
day 1
Recurrence
Time Frame: 1 year
Any regrowth of the pterygium onto the cornea will be considered a recurrence
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kim N Jebodhsingh, MBBS, DABO, The Queen Elizabeth Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2013

Primary Completion (ANTICIPATED)

December 1, 2014

Study Completion (ANTICIPATED)

December 1, 2014

Study Registration Dates

First Submitted

December 3, 2014

First Submitted That Met QC Criteria

December 16, 2014

First Posted (ESTIMATE)

December 22, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

December 30, 2014

Last Update Submitted That Met QC Criteria

December 26, 2014

Last Verified

December 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KJebodhsingh

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pterygium

Clinical Trials on Sutures

3
Subscribe